| 10 | $TRVI Trevi Therapeutics, Inc. News ~ Progress & | Uptick Network | 02/07/2023 11:50:35 AM |
| 9 | $TRVI updates! Trevi Therapeutics, Inc. Discusses | Uptick Network | 01/31/2023 5:58:24 AM |
| 8 | $TRVI News out! Trevi Therapeutics, Inc. ~ | Uptick Network | 01/30/2023 7:10:25 AM |
| 7 | $TRVI Trevi Therapeutics, Inc. Discusses Progress | Uptick Network | 01/25/2023 12:41:17 PM |
| 6 | TRVI 56% v21,4M c2.98 f30,8M H3.20 | znewcar1 | 04/07/2022 10:06:20 PM |
| 5 | TRVI 32% v14,3M c1.15 f25,8M H1.59 | znewcar1 | 03/02/2022 4:14:34 PM |
| 4 | TRVI 36% v3,4M c.8711 f25,8M H.8889 mid day | znewcar1 | 03/01/2022 10:18:00 PM |
| 3 | TRVI 25% v12,3M,015 1.5000 23,971,730 +22.50% | znewcar1 | 10/11/2021 4:19:11 PM |
| 2 | Here is an extremely underpriced (trading under | Biofreak | 05/28/2020 9:23:30 AM |
| 1 | We are watching a very interesting story right | SmallCapTraders | 04/14/2020 9:43:13 PM |
Recent Articles
- Tracy Liberatore Unveils New Podcast Focusing on Med-Legal Topics
- Understanding Neo and Challenger Banks: A 2025 Outlook
- Akston's Innovative Cancer Therapy for Dogs Unveiled in Trials
- Sadaf Foods Launches Exceptional Air Roasted Coffee Line
- Coltura Launches EVQ to Innovate Electric Vehicle Transition
- Naoris Protocol Strengthens Web3 Security at Major Symposium
- Exploring the Growth of AI in the Smart Home Market
- Insights on Reciprocal Insurance Exchanges and Industry Growth
- Verizon Provides Essential Connection During Hurricane Crisis
- NerdPress Unveils Game-Changing AI Bot Blocker for Publishers
- Terrestrial Energy Transitions to Nasdaq with New Ticker IMSR
- Simplifying Financial Stress with H&R Block's Emerald Advance
- Bonk, Inc. Set to Dominate the Growing BONK Crypto Landscape
- CYIOS Corporation Strengthens Investor Relations with New Partner
- REalloys Secures Major Funding for U.S. Critical-Minerals Project
- HeartCore Enterprises Announces Clarification on Payment to Investors
- PolyPid Plans Exciting Third Quarter Update on Finances
- Achieve Life Sciences Prepares to Share Q3 Results and Updates
- Alto Ingredients to Report Q3 Results: Key Information Preview
- Vivos Inc. and Exubrion Therapeutics Enhance Collaboration for Animal Care
- Discover Alliance Entertainment's Upcoming Conference Call
- Alto Ingredients Set for Q3 2025 Financial Results Discussion
- Final Opportunity to Register for C-Level Tech Summit
- Houston American Energy Undergoes Major Renewable Expansion
- Gaia and Steven Greer Launch Unique UAP Disclosure Event
- Aterian Improves Home Comfort with hOmeLabs Dehumidifiers
- HeartCore Enterprises Announces Special One-Time Distribution
- LaFleur Minerals Shifts Focus Towards Mining Production Growth
- Terrestrial Energy Launches Trading on Nasdaq: What to Know
- Natural Gas Services Group Schedules Q3 Earnings Call Update
- CleanSpark Expands Reach with Houston AI Data Center Plans
- Jayud Global Logistics Enhances Manufacturing Ties Through New Deals
- PolyPid Schedules Q3 Financial Results Announcement for 2025
- Osisko Development Secures C$82.5 Million Through Placement
- Belite Bio's Upcoming Presentation at Virtual Investor Event
- ProPhase Labs Unveils Revolutionary Findings in Esophageal Cancer Research
- First Pacific Embraces Investor Engagement at Upcoming Conference
- Osisko Development's Major Funding for Gold Project Launch
- Celebrating Chinese Entrepreneurship: Cultural Festival in Shangqiu
- Moleculin Biotech Cultivates Global Expansion with New Patent
- Community Health Focus: Tackling Record High Syphilis Rates
- American Electric Power Unveils Ambitious Growth Strategy
- KZ Provisioning Welcomes Bri Rosas as CEO to Drive Growth
- Argo Corporation Achieves Remarkable Transit Growth Milestone
- Fed Rate Cuts and the ProShares Nasdaq-100 ETF's Growth
- Erchonia Unveils Innovative Laser Solutions at Annual Expo
- PDS Biotech Pursues Accelerated Path for PDS0101 in Cancer Therapy
- Discover SourcingAI 2.0 from Made-in-China.com for Better Sourcing
- Palantir's Impact on Nvidia: Pioneering AI Software Solutions
- SHARx Revolutionizes U.S. Prescription Drug Access with Transparency
